fbpx Revisions for Europe’s opportunity to open up drug regulation | Science in the net

Revisions for Europe’s opportunity to open up drug regulation

Primary tabs

Revision Operations
8 October, 2010 - 12:15 by Amministratore
This is the published revision.
6 October, 2010 - 12:38 by Amministratore

prossimo articolo

The Glover case. Why Europe has lost its scientific advisor

Someone could have hoped for a different end, but the signs were all clear: few days ago, Juncker made a final decision on cutting the role of the Chief Scientific Advisor at the European Commission. Apparently, this decision came after a struggle between the scientific community and some environmental NGPs, one above all, Greenpeace. But the story is more complicated, and is related to the new geopolitical axis in Europe: science has been (one of) the sacrificial victim in